Literature DB >> 7907988

Further characterization of [3H]ifenprodil binding in rat brain.

K Hashimoto1, C R Mantione, M R Spada, J L Neumeyer, E D London.   

Abstract

The present study was undertaken to characterize [3H]ifenprodil binding in rat brain. [3H]Ifenprodil showed saturable, high-affinity binding at 4 degrees C. Specific binding, defined with 10 microM ifenprodil as a competitor, was inhibited biphasically by the s receptor ligands, GBR 12909, 1,3-di-o-tolylguanidine (DTG), and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine ((+)-3-PPP). At 4 degrees C, 3 microM GBR 12909, which inhibited about 50% of specific binding of [3H]ifenprodil was used to mask sigma receptors. Under these conditions, specific binding of [3H]ifenprodil was inhibited potently by ifenprodil, SL 82.0715, poly(L-arginine), poly(L-lysine), neomycin, ruthenium red, spermine, arcaine and spermidine. In the presence of 3 microM GBR 12909, Zn2+ and Mg2+ partially inhibited specific binding of [3H]ifenprodil at 4 degrees C. In contrast, in the absence of GBR 12909, at 37 degrees C specific binding of [3H]ifenprodil was partially inhibited by Zn2+, but not by Mg2+. The anatomical distribution of [3H]ifenprodil binding at 4 degrees C (GBR 12909 included) in rat brain closely paralleled that of [3H]MK-801 (dizocilpine) binding (r = 0.971, P < 0.005). Without GBR 12909, specific [3H]ifenprodil binding at 37 degrees C was inhibited potently by sigma ligands. In the presence of 3 microM GBR 12909, [3H]ifenprodil binding at 4 degrees C was highest in synaptosomal and myelin fractions; however, without GBR 12909, [3H]ifenprodil binding at 37 degrees C was highest in microsomal and myelin fractions, consistent with the subcellular distribution of sigma receptors. The results suggest that, in the presence of 3 microM GBR 12909, at 4 degrees C, [3H]ifenprodil binds to sites that are sensitive to polyamines and related compounds; and that without GBR 12909, at 37 degrees C, [3H]ifenprodil interacts with sigma receptors in rat brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907988     DOI: 10.1016/0922-4106(94)90211-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.

Authors:  Julie Rachline; Florent Perin-Dureau; Anne Le Goff; Jacques Neyton; Pierre Paoletti
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

2.  Potent inhibition of anoxic depolarization by the sodium channel blocker dibucaine.

Authors:  Heather A Douglas; Jennifer K Callaway; Jeremy Sword; Sergei A Kirov; R David Andrew
Journal:  J Neurophysiol       Date:  2011-01-27       Impact factor: 2.714

3.  The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan.

Authors:  Eun-Joo Shin; Seung-Yeol Nah; Won-Ki Kim; Kwang Ho Ko; Wang-Kee Jhoo; Yong-Kwang Lim; Joo Young Cha; Chieh-Fu Chen; Hyoung-Chun Kim
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation.

Authors:  Justin R Yates; Kerry A Breitenstein; Benjamin T Gunkel; Mallory N Hughes; Anthony B Johnson; Katherine K Rogers; Sara M Shape
Journal:  Pharmacol Biochem Behav       Date:  2016-09-15       Impact factor: 3.533

5.  Effect of naloxone and morphine on arcaine-induced state-dependent memory in rats.

Authors:  Raquele Kipper Mariani; Carlos Fernando Mello; Michelle Melgarejo Rosa; Ana Paula Chiapinotto Ceretta; Keli Camera; Maribel Antonello Rubin
Journal:  Psychopharmacology (Berl)       Date:  2011-03-01       Impact factor: 4.530

6.  Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.

Authors:  Michael L Berger; Dorota Maciejewska; Jean Jacques Vanden Eynde; Madhusoodanan Mottamal; Jerzy Żabiński; Paweł Kaźmierczak; Mateusz Rezler; Ivana Jarak; Ivo Piantanida; Grace Karminski-Zamola; Annie Mayence; Patrick Rebernik; Arvind Kumar; Mohamed A Ismail; David W Boykin; Tien L Huang
Journal:  Bioorg Med Chem       Date:  2015-06-14       Impact factor: 3.641

7.  Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias.

Authors:  Spiridon Konitsiotis; Christos Tsironis; Dimitrios N Kiortsis; Angelos Evangelou
Journal:  Psychopharmacology (Berl)       Date:  2006-03-04       Impact factor: 4.530

8.  Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.

Authors:  Tamaki Ishima; Kenji Hashimoto
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

9.  GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia.

Authors:  Amy E Geddes; Xu-Feng Huang; Kelly A Newell
Journal:  BMC Psychiatry       Date:  2014-10-08       Impact factor: 3.630

10.  Moderate prenatal alcohol exposure enhances GluN2B containing NMDA receptor binding and ifenprodil sensitivity in rat agranular insular cortex.

Authors:  Clark W Bird; Felicha T Candelaria-Cook; Christy M Magcalas; Suzy Davies; C Fernando Valenzuela; Daniel D Savage; Derek A Hamilton
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.